Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare, malignant, neoplastic disease characterized by clonal proliferation of myeloid and/or lymphoid precursors harboring rearrangements in the PDGFRB gene, in the blood, bone marrow and often other tissues as well (spleen, lymph nodes, skin, etc.). It usually presents as chronic myelomonocytic leukemia with eosinophilia, chronic eosinophilic leukemia, atypical chronic myelogenous leukemia, juvenile myelomonocytic leukemia, myelodysplastic syndrome, acute myeloid leukemia or acute lymphoblastic leukemia. Patients usually present with anemia, leukocytosis, monocytosis, eosinophilia and/or splenomegaly, or systemic symptoms, such as fever, sweating and/or weight loss.
Biomarker and diagnostic research for myeloid neoplasm associated with PDGFRB rearrangement has been reported in the published literature.
No clinical trials have been registered for myeloid neoplasm associated with PDGFRB rearrangement.
19 publications have been identified in PubMed for myeloid neoplasm associated with PDGFRB rearrangement. Research spans Case Report / Case Series (63%), Review / Meta-Analysis (16%), and Basic Science / Preclinical (16%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 12 | 63% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 11:40 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries |
3 |
16% |
Laboratory research | 3 | 16% |
Testing and diagnosis research | 1 | 5% |
Ding Q (2026). [PMID: 42042189](https://pubmed.ncbi.nlm.nih.gov/42042189/). *Hematol Rep*. [Case Report / Case Series]
Čemažar L (2026). [PMID: 41530508](https://pubmed.ncbi.nlm.nih.gov/41530508/). *Annals of hematology*. [Review / Meta-Analysis]
Salmon M (2026). [PMID: 41254115](https://pubmed.ncbi.nlm.nih.gov/41254115/). *Leukemia*. [Basic Science / Preclinical]
Goel N (2026). [PMID: 41090541](https://pubmed.ncbi.nlm.nih.gov/41090541/). *International journal of laboratory hematology*. [Case Report / Case Series]
Krishnan Y (2026). [PMID: 41894669](https://pubmed.ncbi.nlm.nih.gov/41894669/). *Journal of pediatric hematology/oncology*. [Basic Science / Preclinical]
Barbato C (2026). [PMID: 41596308](https://pubmed.ncbi.nlm.nih.gov/41596308/). *International journal of molecular sciences*. [Case Report / Case Series]
Gao M (2026). [PMID: 42043473](https://pubmed.ncbi.nlm.nih.gov/42043473/). *Ann Hematol*. [Case Report / Case Series]
Hoff FW (2025). [PMID: 40200571](https://pubmed.ncbi.nlm.nih.gov/40200571/). *The American journal of case reports*. [Case Report / Case Series]
Vanhevel J (2025). [PMID: 40533930](https://pubmed.ncbi.nlm.nih.gov/40533930/). *Journal of cellular and molecular medicine*. [Diagnostic / Biomarker]
Andersen K (2025). [PMID: 39730178](https://pubmed.ncbi.nlm.nih.gov/39730178/). *Cancer genomics & proteomics*. [Case Report / Case Series]